melanoma
Selected indexed studies
- Histopathologic classification and prognostic factors of melanoma: a 2021 update. (Ital J Dermatol Venerol, 2021) [PMID:33982546]
- The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. (Arch Pathol Lab Med, 2020) [PMID:32057276]
- Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions. (Front Immunol, 2021) [PMID:34149718]
_Worker-drafted node — pending editorial review._
Connections
melanoma is a risk factor for
Sources
- Histopathologic classification and prognostic factors of melanoma: a 2021 update. (2021) pubmed
- The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. (2020) pubmed
- Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions. (2021) pubmed
- Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990-2021. (2025) pubmed
- Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. (2009) pubmed
- Melanoma in Special Populations: Pediatrics, Elders, Pregnant Women. (2025) pubmed
- Decoding melanoma's cellular mosaic to unlock immunotherapy potential. (2025) pubmed
- Radiation Therapy for Metastatic Melanoma. (2025) pubmed
- Lesional Markers and Precursors of Melanoma. (2025) pubmed
- Canonical Signaling Pathways in Melanoma. (2021) pubmed